Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Notes Payables (2022)

CervoMed (CRVO) has disclosed Notes Payables for 6 consecutive years, with $12.4 million as the latest value for Q4 2022.

  • Quarterly Notes Payables changed N/A to $12.4 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $12.4 million through Dec 2022, changed N/A year-over-year, with the annual reading at $12.4 million for FY2022, N/A changed from the prior year.
  • Notes Payables hit $12.4 million in Q4 2022 for CervoMed, up from $200000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $12.4 million in Q4 2022 to a low of $12.4 million in Q4 2022.